In addition, manipulating the DYRK3 expression in HCC cells demonstrated an inverse correlation with proliferation rates both in vitro and in tumor xenograft models, as well as with the metastatic potential of the tumor cells, further evidencing that DYRK3 fulfills a tumor-suppressor role in this type of cancer [167]. This evidence concerns the gene DYRK3 and hepatocellular carcinoma.